ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.49
-0.43%
US Tech 100
19,408.40
0.00%
S&P 500
5,487.03
0.25%
US Dollar vs CAD
1.37125
0.05%
Bitcoin
65,815.66
1.31%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. First Wave BioPharma Inc (FWBI)

  7. First Wave BioPharma Inc (FWBI) News

FWBI First Wave BioPharma Inc

2.96
0.00 (0.00%)
Jun 19 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
First Wave BioPharma Inc FWBI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.96 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.96
more quote information »

Recent News

Date Time Source Heading
6/17/202416:23EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
6/14/202416:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
6/10/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
6/05/202416:15EDGAR2Form 8-K - Current report
5/31/202416:25EDGAR2Form S-3 - Registration statement under Securities Act of..
5/30/202416:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/30/202416:18EDGAR2Form 8-K/A - Current report: [Amend]
5/16/202406:16EDGAR2Form 8-K - Current report
5/16/202406:00GLOBEFirst Wave BioPharma Changes Name to Entero Therapeutics
5/14/202416:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202416:26EDGAR2Form 8-K - Current report
5/13/202415:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/10/202406:55GLOBEFirst Wave BioPharma, Inc. to raise approximately $1.1..
5/09/202406:00GLOBEFirst Wave BioPharma and Celiac Journey to Host Nasdaq Event..
5/08/202416:16EDGAR2Form 8-K/A - Current report: [Amend]
4/24/202406:00GLOBEFirst Wave BioPharma Announces Invited Paper for Special..
4/17/202406:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
4/15/202406:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Participate in..
3/18/202406:00GLOBEFirst Wave BioPharma Announces Two Abstracts on Celiac..
3/14/202405:00GLOBEFirst Wave BioPharma Announces Completion of Business..
3/05/202416:26EDGAR2Form 8-K - Current report
3/05/202406:00GLOBEFirst Wave BioPharma to Participate In ‘Fireside Chat’ at..
3/04/202416:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/202407:00GLOBEFirst Wave BioPharma, Inc. to Raise Approximately $4.0..
2/13/202406:00GLOBEFirst Wave BioPharma CEO to Present at the BIO CEO &..
1/23/202406:00GLOBEFirst Wave BioPharma to Present at the DealFlow MicroCap..
1/18/202415:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
1/17/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202406:00GLOBEFirst Wave BioPharma CEO to Present at the Sequire Investor..
1/08/202416:14EDGAR2Form S-3 - Registration statement under Securities Act of..
1/04/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202407:22EDGAR2Form 8-K - Current report
1/04/202405:00GLOBEFirst Wave BioPharma Chairman and CEO Issues Letter to..
1/03/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/28/202311:21EDGAR2Form RW - Registration Withdrawal Request
12/27/202316:23EDGAR2Form 8-K - Current report
12/27/202310:55GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
12/27/202307:04EDGAR2Form S-1/A - General form for registration of securities..
12/27/202305:15EDGAR2Form 8-K - Current report
12/27/202305:00GLOBEFirst Wave BioPharma Announces Streamlining of Clinical..
12/18/202306:00EDGAR2Form 8-K - Current report
12/18/202305:00GLOBEFirst Wave BioPharma Announces Entry into Term Sheet for..
12/15/202320:48EDGAR2Form S-1/A - General form for registration of securities..
12/14/202308:15EDGAR2Form 8-K - Current report
12/14/202308:15GLOBEFirst Wave BioPharma Announces 1-for-20 Reverse Stock Split..
12/06/202306:00GLOBEFirst Wave BioPharma to Participate in BIO Partnering @JPM..
12/05/202306:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Moderate Panel..
11/13/202315:20EDGAR2Form DEF 14A - Other definitive proxy statements
11/13/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
FWBI
First Wave BioPharma
TG
FAU
Forvia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved